New HIV Drug Already in Use in Nigeria – Govt

Jul 4, 2017 0

The Nigerian Government has said Dolutegravir (DTG), the new drug for the treatment of HIV/AIDS, is already being used in Nigeria, although only by those who can afford it because of its high cost. DTG can improve and prolong the lives of people who suffer side effect and resistance to other treatments and are the drug of choice for people with HIV in high-income countries who have never taken anti-retroviral therapy before and for those who have developed resistance to other treatments. A report last week had stated that Unitaid, a global health initiative, is set to roll out a generic version of the drug so that it can become available to tens of thousands of people who at the moment cannot afford the patented version. According to the report, DTG, first approved in the U.S. ...

Read More

VR therapy may help reduce pain: Study

Jun 19, 2017 0

A virtual reality therapy that involves watching calming 3D videos can significantly reduce pain for hospitalized patients, according to a study. Researchers from Cedars-Sinai Medical Centre in the US examined 100 hospitalized patients who reported pain scores of greater than three on the Numeric Pain Rating Scale from zero to 10. Fifty patients received virtual reality (VR) therapy consisting of wearing VR goggles to watch calming video content such as helicopter rides over scenic portions of Iceland, or imagery of swimming in the ocean with whales. Those patients reported a 24 per cent drop in pain scores after using the virtual reality goggles. Another 50 patients viewed a standard, two-dimensional nature video, depicting relaxing scenes with a calming music audio track, on a close-proximity screen. Although those patients also experienced a reduction in pain, the decrease of 13.2 per cent was less dramatic. ...

Read More

Australia: New method to make lung cancer drug trials more successful

Jun 15, 2017 0

Australian researchers have developed a new method for finding participants in clinical trials of lung cancer drugs, it was announced on Wednesday. Researchers from Melbourne’s Walter and Eliza Hall Institute (WEHI) were optimistic that the new recruitment process will boost the success rate of drugs being trialled as treatments for lung squamous cell carcinoma, the second most common type of lung cancer. By mimicking the complexity of human tumours with a research tool, the scientists were able to identify a “biomarker” which could serve as an indication as to which patients would better respond to certain drugs, Xinhua news agency reported. Marie-Liesse Asselin-Labat, the lead author of the study, said patients with the biomarker were more likely to respond positively to fibroglast growth factor receptor (FGFR) drugs. “We found that high levels of the anti-cancer drug’s target, FGFR1, in a patient’s tumour ribonucleic acid (RNA) were a better predictor of their potential response to the drug than the current tests that are used,” Asselin-Labat said on Wednesday. ...

Read More

Cancer virus can be eliminated with baking soda, claims Italian doctor

Jun 14, 2017 0

Cancer is one of the most terrifying diseases that mankind has to deal with. Perhaps, the very thought of being diagnosed with cancer can be devastating as it is an event that goes hand-in-hand with fear and dread upon detection of the disease, followed by rounds of chemotherapy and treatments. While not every diagnosis results in termination of the victim, enough of them do so, mainly, because of lack of awareness of cancer, which leads to delay in detection of the disease. Even when diagnosed and treated early, cancer still has a reasonable chance to kill the patient. According to the World Health Organisation (WHO), cancer is the second leading cause of death globally, and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer. Cancer is a group of diseases in which abnormal cells divide uncontrollably and spread to other parts of the body. It arises from the transformation of normal cells into tumour cells in a multistage process that generally... ...

Read More

New anti-platelet drug based on snake venom may be safer

Jun 12, 2017 0

Taipei: An anti-platelet drug based on snake venom that may prevent blood cells from forming blood clots may be much safer for treating heart disease, according to new research. When a person gets wounded, blood cells called platelets arrive on the scene and group together to form a clot that stops the bleeding.Anti-platelet drugs prevent these platelets from clumping together and forming blood clots and is widely used to treat heart disease.  However, current anti-platelet drugs cause excessive bleeding after injury. The new drug — designed by researchers from the National Taiwan University — is based on a protein in the snake venom and prevents platelets from clotting when it was mixed with blood. When mice was administered the new drug, it showed slower blood clot formation compared to untreated mice.  In addition, the treated mice did not bleed longer than untreated mice. The new drug, detailed in the journal Arteriosclerosis, Thrombosis and Vascular Biology, interacts with the protein glycoprotein VI (GPVI) that sits on the surface of platelets, the... ...

Read More

Scottish scientists to develop tools to stop heart attacks

Jun 1, 2017 0

Scientists at the University of Edinburgh are to lead a £1.8m project to develop a way of treating heart attacks before they happen. Around 10,000 people in Scotland die every year when fatty deposits blocking the arteries suddenly rupture. The British Heart Foundation-funded project will make use of new advanced scanning techniques. The cutting-edge research would enable doctors to pinpoint people at higher risk of heart attack.  Coronary heart disease is the most common cause of death worldwide, killing one person in the UK every seven minutes, usually through heart attack. The Edinburgh study is focused on improving detection of coronary atherothrombosis, a condition in which fatty deposits blocking the arteries – known as plaques – rupture without warning.  ...

Read More

Human brain can spot early-stage disease in others to avoid sick people

May 26, 2017 0

A new study suggests that human brain can discover early-stage disease in others to help us avoid sick people. According to the study, human sense of vision and smell are enough to make us aware that someone has a disease even before it breaks out. The human immune system is effective at combating disease, but since it entails a great deal of energy expenditure, disease avoidance should be part of our survival instinct. The new study now shows that this is indeed the case. Principal investigator Mats Olsson, Professor at Karolinska Institutet in Sweden said,”The study shows us that the human brain is actually very good at discovering this and that this discovery motivates avoidance behaviour. ...

Read More

Frozen ‘space sperm’ passes fertility test

May 23, 2017 0

Healthy baby mice have been born using freeze-dried sperm stored in the near-weightless environment of space. The Japanese team behind the gravity-breaking experiment on the International Space Station (ISS) says it shows that transporting the seeds of life away from Earth is feasible.  Sperm banks could even be made on the Moon as a back-up for Earth disasters, they told a leading science journal. It is unclear if this will ever help humans populate space, however.  Sustaining life in space is challenging to say the least.  On the ISS, radiation is more than 100 times higher than on Earth. The average daily dose of 0.5mSv from the cosmic rays is enough to damage the DNA code inside living cells, including sperm.  Microgravity also does strange things to sperm.  ...

Read More